secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0000914475-21-000064
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine Biosciences' license with Heptares effective; $100M upfront due
--------------------------------------------------------------------------

- Collaboration and License Agreement with Heptares Therapeutics becomes effective Dec 22, 2021 after HSR clearance.
- Neurocrine to pay Heptares $100M upfront within ten days of effective date.
- Agreement originally entered Nov 22, 2021; HSR waiting period expired Dec 22, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447521000064/0000914475-21-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447521000064/nbix-20211222.htm
  HTML page:      https://secwatch.observer/filing/0000914475-21-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer